NVONYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NONOF
NOVO NORDISK A S
Financials through fiscal 2025, year ended Dec 31, 2025
$38.42−0.41 (-1.06%)
Close on Oct 19, 2026
Novo Nordisk A S statistics
Financials through Dec 31, 2025, price-based ratios appear once a share price is available
Valuation
| Market Cap | 1.15T DKK |
|---|---|
| Enterprise Value | 1.26T DKK |
| PE Ratio | 11.14 |
| PS Ratio | 3.71 |
| P/FCF Ratio | 19.43 |
| P/OCF Ratio | 9.62 |
Enterprise value
| EV / Sales | 4.08 |
|---|---|
| EV / EBITDA | 8.87 |
| EV / EBIT | 9.89 |
| EV / FCF | 21.41 |
Income (trailing twelve months)
| Revenue | 309.06B DKK |
|---|---|
| Gross Profit | 250.28B DKK |
| Operating Income | 127.66B DKK |
| Pretax Income | 130.54B DKK |
| EBITDA | 142.32B DKK |
| EPS (Diluted) | 23.03 DKK |
Margins
| Gross Margin | 81.0% |
|---|---|
| Operating Margin | 41.3% |
| Pretax Margin | 42.2% |
| EBITDA Margin | 46.1% |
| FCF Margin | 19.1% |
Returns
| Return on Capital Employed (ROCE) | 39.0% |
|---|
Growth
| Revenue Growth (YoY) | 6.43% |
|---|---|
| EPS Growth (YoY) | 1.77% |
| FCF Growth (YoY) | -20.1% |
| Revenue Growth (3Y CAGR) | 20.4% |
| Revenue Growth (5Y CAGR) | 19.5% |
| EPS Growth (3Y CAGR) | 23.5% |
| EPS Growth (5Y CAGR) | 20.7% |
Balance sheet
| Cash & Short-Term Investments | 26.46B DKK |
|---|---|
| Total Debt | 142.98B DKK |
| Net Cash (Debt) | -116.51B DKK |
| Net Cash Per Share | -26.09 DKK |
| Working Capital | -43.21B DKK |
Financial position
| Current Ratio | 0.80 |
|---|---|
| Quick Ratio | 0.45 |
| Debt / EBITDA | 1.00 |
| Debt / FCF | 2.42 |
| Net Debt / EBITDA | 0.82 |
| Interest Coverage | 18.83 |
Cash flow (trailing twelve months)
| Operating Cash Flow | 119.10B DKK |
|---|---|
| Capital Expenditures | -60.14B DKK |
| Free Cash Flow | 58.96B DKK |
| FCF Per Share | 13.21 DKK |
Efficiency
| Asset Turnover | 0.61 |
|---|---|
| Inventory Turnover | 1.30 |
| Revenue Per Employee | 4.45M DKK |
| Employee Count | 69,505 |
Dividends and yields
| FCF Yield | 5.15% |
|---|---|
| Buyback Yield | 0.12% |
| Shareholder Yield | 0.12% |
| FCF Payout Ratio | 87.8% |
Shares
| Shares Outstanding | 4,465,000,000 |
|---|---|
| Shares Change (YoY) | -0.34% |
| Float | 4,465,000,000 |
| Shares Held by Insiders | 0.00% |
| Shares Held by Institutions | 7.32% |
Taxes
| Income Tax | 28.11B DKK |
|---|---|
| Effective Tax Rate | 21.5% |
Scores
| Altman Z-Score | 3.72 |
|---|
Calculated by StockData from Novo Nordisk A S's SEC filings. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.